BioNTech’s experimental bispecific cancer drug pumitamig helped shrink tumors in three-quarters of people with small cell lung cancer who were enrolled in a Phase 2 trial, and stabilized disease in ...

A new treatment for cats with oral cancer could also help humans. Researchers from UCSF, UC Davis, and the University of Pittsburgh enrolled 20 cats in a clinical trial. After treatment, many remained ...

Scientists at UC San Diego have identified a new drug, ION224, that could transform the treatment of MASH, a dangerous form ...

Head and neck squamous cell carcinoma (HNSCC) is approximately the seventh most common cancer in humans with an estimated 900,000 new cases globally. As a surgeon, Jennifer Grandis, MD, a physician ...

In an experiment using mice, Japanese researchers reported success in targeting and shrinking cancer cells with natural bacteria, a development they said will pave the way for new treatments.

Assistant Professor of Oncology Division of Pediatric Oncology Department of Immunology Department of Radiology Roswell Park Comprehensive Cancer Center Assistant Clinical Professor Department of ...

When Nat Myers first went into the hospital back in February, he said he thought he was dealing with some type of lung infection. It turned out to be something far more sinister, and the 33-year-old ...

A single fecal microbiota transplant in obese teens was linked to long-lasting metabolic improvements, including smaller waistlines, reduced body fat, lower inflammation, and better cholesterol levels ...

The FDA approved Monjuvi with Revlimid and Rituxan for follicular lymphoma, the same combination that brought survivor Troy Anderson a lasting response. The U.S. Food and Drug Administration approved ...